NCT06717568 3D Depth Camera-Based Assessment of Adolescent Idiopathic ScoliosisUsing a Depth Camera
| NCT ID | NCT06717568 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The First Affiliated Hospital of Zhejiang Chinese Medical University |
| Condition | Adolescent Idiopathic Scoliosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 80 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 80 participants in total. It began in 2022-01-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Adolescent Idiopathic Scoliosis (AIS) is a common spinal deformity affecting adolescent health, and early diagnosis and accurate assessment are crucial for preventing disease progression. Traditional assessment indicators, such as the trunk rotation angle (ATR) and Cobb angle, rely on clinical examinations and X-ray imaging, which have certain limitations, including radiation exposure and insufficient sensitivity. The Back Height Difference (BHD), as a quantitative measure of the back surface morphology, may reflect the degree of trunk deformity caused by scoliosis. The use of the Kinect v2 depth camera to capture three-dimensional point cloud data of the back provides a high-precision, radiation-free assessment method.
Eligibility Criteria
Inclusion Criteria: (1) Adolescents aged 10-18 years, diagnosed with adolescent idiopathic scoliosis (AIS) with a Cobb angle ≥10°; (2) No history of spinal surgery or other corrective treatments; (3) Able to undergo short-term inpatient treatment (5 days) and comply with study procedures. Exclusion Criteria: (1) Patients with congenital, neuromuscular, or other secondary scoliosis; (2) Presence of major comorbidities affecting spinal structure or muscle tone (e.g., spinal cord injury, muscular dystrophy); (3) Patients unable to complete standardized assessment procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06717568 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Adolescent Idiopathic Scoliosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06717568 currently recruiting?
Yes, NCT06717568 is actively recruiting participants. Contact the research team at 506776186@qq.com for enrollment information.
Where is the NCT06717568 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06717568 clinical trial?
NCT06717568 is sponsored by The First Affiliated Hospital of Zhejiang Chinese Medical University. The trial plans to enroll 80 participants.